Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $87,531 | 39 | 87.2% |
| Travel and Lodging | $9,456 | 25 | 9.4% |
| Food and Beverage | $3,317 | 47 | 3.3% |
| Education | $32.27 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $99,689 | 96 | $0 (2024) |
| ABBVIE INC. | $217.28 | 2 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $209.46 | 2 | $0 (2021) |
| Nalpropion Pharmaceuticals LLC | $48.81 | 3 | $0 (2019) |
| GENZYME CORPORATION | $40.60 | 1 | $0 (2022) |
| Currax Pharmaceuticals LLC | $29.15 | 2 | $0 (2022) |
| Orexigen Therapeutics, Inc. | $24.74 | 1 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $23.32 | 2 | $0 (2018) |
| BAXTER HEALTHCARE | $21.67 | 1 | $0 (2018) |
| Roche Diagnostics Corporation | $18.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,855 | 23 | Novo Nordisk Inc ($23,855) |
| 2023 | $17,317 | 16 | Novo Nordisk Inc ($17,317) |
| 2022 | $36,784 | 36 | Novo Nordisk Inc ($36,607) |
| 2021 | $15,482 | 17 | Novo Nordisk Inc ($15,366) |
| 2020 | $6,407 | 6 | Novo Nordisk Inc ($6,407) |
| 2019 | $35.76 | 2 | Novo Nordisk Inc ($20.35) |
| 2018 | $387.54 | 8 | Novo Nordisk Inc ($116.38) |
| 2017 | $67.41 | 4 | Orexigen Therapeutics, Inc. ($24.74) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $110.76 | General |
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,281.25 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $69.68 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,093.75 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $365.82 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $305.12 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $12.35 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,093.75 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $77.99 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $159.50 | General |
| Category: Obesity | ||||||
| 07/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,042.25 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $584.51 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $271.42 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $196.24 | General |
| Category: Obesity | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Obesity | ||||||
| 04/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,843.75 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $182.24 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Obesity | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,281.25 | General |
| Category: Obesity | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 18 | 38 | $8,968 | $2,948 |
| 2021 | 3 | 54 | 166 | $37,717 | $13,325 |
| 2020 | 2 | 47 | 152 | $34,276 | $9,858 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 38 | $8,968 | $2,948 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 143 | $33,748 | $11,920 | 35.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $3,804 | $1,374 | 36.1% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 11 | 11 | $165.00 | $30.51 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 131 | $30,916 | $8,772 | 28.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 21 | $3,360 | $1,087 | 32.3% |
About Dr. Sherri Thomas, DO
Dr. Sherri Thomas, DO is a Internal Medicine healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215107826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sherri Thomas, DO has received a total of $100,336 in payments from pharmaceutical and medical device companies, with $23,855 received in 2024. These payments were reported across 112 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($87,531).
As a Medicare-enrolled provider, Thomas has provided services to 119 Medicare beneficiaries, totaling 356 services with total Medicare billing of $26,131. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Lincoln, NE
- Active Since 03/11/2008
- Last Updated 07/22/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215107826
Products in Payments
- Saxenda (Drug) $55,911
- Wegovy (Drug) $43,575
- STELARA (Biological) $209.46
- SKYRIZI (Biological) $117.52
- CONTRAVE (Drug) $102.70
- Mavyret (Drug) $99.76
- RYBELSUS (Drug) $60.26
- DUPIXENT (Biological) $40.60
- TROKENDI XR (Drug) $23.32
- TISSEEL (Biological) $21.67
- RS Harmony Test Related Products (Device) $18.98
- NASCOBAL (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lincoln
Brock Cookman, D.o, D.O
Internal Medicine — Payments: $694,509
Dr. Ryan Martin, Md, MD
Internal Medicine — Payments: $414,185
Matthew Johnson, M.d, M.D
Internal Medicine — Payments: $307,471
Frank D'alessandro, Md Inc, MD INC
Internal Medicine — Payments: $86,860
Peter Gallagher, M.d, M.D
Internal Medicine — Payments: $83,162
Dr. Jeffrey Wayne, Md, MD
Internal Medicine — Payments: $81,162